Crossref
Glucocorticoid reduces the efficacy of afatinib on the head and neck squamous cell carcinoma
BIOCELL · 2023 · 47 (2) · 329-338
DOI: 10.32604/biocell.2023.023489 ↗Kurz gefasst
Fachartikel in der Zeitschrift BIOCELL, 2023. Verfasst von DONGYANG WANG und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
WANG, D., CHEN, Y., HUANG, J., ZHANG, Y., SUN, C., & SHEN, Y. (2023). Glucocorticoid reduces the efficacy of afatinib on the head and neck squamous cell carcinoma. BIOCELL, 47(2), 329-338. https://doi.org/10.32604/biocell.2023.023489
Vancouver
WANG D, CHEN Y, HUANG J, ZHANG Y, SUN C, SHEN Y. Glucocorticoid reduces the efficacy of afatinib on the head and neck squamous cell carcinoma. BIOCELL. 2023;47(2):329-338. doi:10.32604/biocell.2023.023489
BibTeX
@article{WANG2023,
author = {WANG, DONGYANG and CHEN, YI and HUANG, JING and ZHANG, YOU and SUN, CHONGKUI and SHEN, YINGQIANG},
title = {Glucocorticoid reduces the efficacy of afatinib on the head and neck squamous cell carcinoma},
journal = {BIOCELL},
year = {2023},
volume = {47},
number = {2},
pages = {329--338},
doi = {10.32604/biocell.2023.023489}
}
EUVIMED